The Gut Microbiome of Heart Failure With Preserved Ejection Fraction

被引:87
|
作者
Beale, Anna L. [1 ,2 ,3 ]
O'Donnell, Joanne A. [4 ]
Nakai, Michael E. [4 ]
Nanayakkara, Shane [1 ,2 ]
Vizi, Donna [2 ]
Carter, Kaye [2 ]
Dean, Eliza [2 ]
Ribeiro, Rosilene, V [5 ]
Yiallourou, Stephanie [6 ]
Carrington, Melinda J. [6 ]
Marques, Francine Z. [1 ,4 ]
Kaye, David M. [1 ,2 ,3 ]
机构
[1] Baker Heart & Diabet Inst, Heart Failure Res Grp, POB 6492 St Kilda Rd Cent, Melbourne, Vic 8008, Australia
[2] Alfred Hosp, Dept Cardiol, Melbourne, Vic, Australia
[3] Monash Univ, Fac Sci, Sch Biol Sci, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia
[4] Monash Univ, Fac Sci, Sch Biol Sci, Hypertens Res Lab, Melbourne, Vic, Australia
[5] Univ Sydney, Charles Perkins Ctr, Sch Life & Environm Sci, Sydney, NSW, Australia
[6] Baker Heart & Diabet Inst, Preclin Dis & Prevent, Melbourne, Vic, Australia
来源
基金
英国医学研究理事会;
关键词
16S; heart failure with preserved ejection fraction; microbiome; microbiota; short-chain fatty acids; TRIMETHYLAMINE-N-OXIDE; FLORA;
D O I
10.1161/JAHA.120.020654
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Risk factors for heart failure with preserved ejection fraction (HFpEF) include hypertension, age, sex, and obesity. Emerging evidence suggests that the gut microbiota independently contributes to each one of these risk factors, potentially mediated via gut microbial-derived metabolites such as short-chain fatty acids. In this study, we determined whether the gut microbiota were associated with HFpEF and its risk factors. Methods and Results We recruited 26 patients with HFpEF and 67 control participants from 2 independent communities. Patients with HFpEF were diagnosed by exercise right heart catheterization. We assessed the gut microbiome by bacterial 16S rRNA sequencing and food intake by the food frequency questionnaire. There was a significant difference in alpha-diversity (eg, number of microbes) and beta-diversity (eg, type and abundance of microbes) between both cohorts of controls and patients with HFpEF (P=0.001). We did not find an association between beta-diversity and specific demographic or hemodynamic parameters or risk factors for HFpEF. The Firmicutes to Bacteroidetes ratio, a commonly used marker of gut dysbiosis, was lower, but not significantly so (P=0.093), in the patients with HFpEF. Compared with controls, the gut microbiome of patients with HFpEF was depleted of bacteria that are short-chain fatty acid producers. Consistent with this, participants with HFpEF consumed less dietary fiber (17.6 +/- 7.7 versus 23.2 +/- 8.8 g/day; P=0.016). Conclusions We demonstrate key changes in the gut microbiota in patients with HFpEF, including the depletion of bacteria that generate metabolites known to be important for cardiovascular homeostasis. Further studies are required to validate the role of these gut microbiota and metabolites in the pathophysiology of HFpEF.
引用
收藏
页数:25
相关论文
共 50 条
  • [41] Is heart failure with preserved ejection fraction a 'dementia' of the heart?
    Tini, Giacomo
    Cannata, Antonio
    Canepa, Marco
    Masci, Pier Giorgio
    Pardini, Matteo
    Giacca, Mauro
    Sinagra, Gianfranco
    Marchionni, Niccolo
    Del Monte, Federica
    Udelson, James E.
    Olivotto, Iacopo
    HEART FAILURE REVIEWS, 2022, 27 (02) : 587 - 594
  • [42] Heart Failure With Preserved Ejection Fraction In Perspective
    Pfeffer, Marc A.
    Shah, Amil M.
    Borlaug, Barry A.
    CIRCULATION RESEARCH, 2019, 124 (11) : 1598 - 1617
  • [43] Nitrates in Heart Failure with Preserved Ejection Fraction
    O'Rourke, Michael F.
    Safar, Michel E.
    Nichols, Wilmer W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (16): : 1587 - 1588
  • [44] Heart Failure with Preserved Ejection Fraction in Women
    Tibrewala, Anjan
    Yancy, Clyde W.
    HEART FAILURE CLINICS, 2019, 15 (01) : 9 - 18
  • [45] Imaging in Heart Failure with Preserved Ejection Fraction
    Gupta, Deepak K.
    Solomon, Scott D.
    HEART FAILURE CLINICS, 2014, 10 (03) : 419 - +
  • [46] Finerenone in Heart Failure with Preserved Ejection Fraction
    Pedreira-Bouzas, Jorge
    Pousada-Fonseca, Alvaro
    Sierra-Sanchez, Jesus F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (03): : 308 - 309
  • [47] Heart failure with preserved ejection fraction in Asia
    Tromp, Jasper
    Teng, Tiew-Hwa
    Tay, Wan Ting
    Hung, Chung Lieh
    Narasimhan, Calambur
    Shimizu, Wataru
    Park, Sang Weon
    Liew, Houng Bang
    Ngarmukos, Tachapong
    Reyes, Eugene B.
    Siswanto, Bambang B.
    Yu, Cheuk-Man
    Zhang, Shu
    Yap, Jonathan
    MacDonald, Michael
    Ling, Lieng Hsi
    Leineweber, Kirsten
    Richards, A. Mark
    Zile, Michael R.
    Anand, Inder S.
    Lam, Carolyn S. P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (01) : 23 - 36
  • [48] Treatment of Heart Failure with Preserved Ejection Fraction
    Iliesiu, Adriana Mihaela
    Hodorogea, Andreea Simona
    HEART FAILURE: FROM RESEARCH TO CLINICAL PRACTICE, VOL 3, 2018, 1067 : 67 - 87
  • [49] Pathophysiology of Heart Failure with Preserved Ejection Fraction
    Youn, Jong-Chan
    Ahn, Yuran
    Jung, Hae Ok
    HEART FAILURE CLINICS, 2021, 17 (03) : 327 - 335
  • [50] Empagliflozin in Heart Failure with a Preserved Ejection Fraction
    不详
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (21):